Functional gastrointestinal disorders in children: agreement between Rome III and Rome IV diagnoses.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 23 12 2020
accepted: 04 03 2021
revised: 26 02 2021
pubmed: 19 3 2021
medline: 24 6 2021
entrez: 18 3 2021
Statut: ppublish

Résumé

To evaluate the agreement between the Rome III and Rome IV criteria in diagnosing pediatric functional gastrointestinal disorders (FGIDs), we conducted a prospective cohort study in a public school in Cali, Colombia. Children and adolescents between 11 and 18 years of age were given the Spanish version of the Questionnaire on Pediatric Functional Gastrointestinal Disorders Rome III version on day 0 and Rome IV version on day 2 (48 h later). The study protocol was completed by 135 children. Thirty-nine (28.9%) children were excluded because of not following the instructions of the questionnaire. The final analysis included data of 96 children (mean 15.2 years old, SD ± 1.7, 54% girls). Less children fulfilled the criteria for an FGID according to Rome IV compared to Rome III (40.6% vs 29.2%, p=0.063) resulting in a minimal agreement between the two criteria in diagnosing an FGID (kappa 0.34, agreement of 70%). The prevalence of functional constipation according to Rome IV was significantly lower compared to Rome III (13.5% vs 31.3%, p<0.001), whereas functional dyspepsia had a higher prevalence according to Rome IV than Rome III (11.5% vs 0%).Conclusion: We found an overall minimal agreement in diagnosing FGIDs according to Rome III and Rome IV criteria. This may be partly explained by the differences in diagnostic criteria. However, limitations with the use of questionnaires to measure prevalence have to be taken into account. What is Known: • The Rome IV criteria replaced the previous Rome III criteria providing updated criteria to diagnose functional gastrointestinal disorders (FGIDs). • Differences found between Rome IV and historic Rome III FGID prevalence may have been affected by changes in prevalence over time or differences in sample characteristics. What is New: • We found a minimal agreement between Rome III and Rome IV FGID diagnosis, especially in the diagnoses of functional constipation, irritable bowel syndrome, and functional dyspepsia. • The minimal agreement may be partly explained by changes in diagnostic criteria, but limitations with the use of questionnaires to measure prevalence have to be taken into account.

Identifiants

pubmed: 33733289
doi: 10.1007/s00431-021-04013-2
pii: 10.1007/s00431-021-04013-2
pmc: PMC8195790
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2297-2303

Références

J Neurogastroenterol Motil. 2019 Jan 31;25(1):123-128
pubmed: 30646483
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
J Pediatr. 2018 Apr;195:134-139
pubmed: 29398057
Gastroenterology. 2006 Apr;130(5):1527-37
pubmed: 16678566
Expert Rev Gastroenterol Hepatol. 2017 Mar;11(3):193-201
pubmed: 28092724
Neurogastroenterol Motil. 2013 Apr;25(4):302-e246
pubmed: 23216900
Gastroenterology. 2006 Apr;130(5):1519-26
pubmed: 16678565
Gastroenterology. 2016 Feb 19;:
pubmed: 27144617
Curr Gastroenterol Rep. 2020 Mar 19;22(5):21
pubmed: 32193635
J Pediatr. 2018 Aug;199:212-216
pubmed: 29747935
Gastroenterology. 2016 Feb 15;:
pubmed: 27144631
Turk J Gastroenterol. 2016 Mar;27(2):129-35
pubmed: 27015618
Eur J Pediatr. 1997 Mar;156(3):178-81
pubmed: 9083754
Bol Med Hosp Infant Mex. 2017 Nov - Dec;74(6):407-412
pubmed: 29382524
J Pediatr Gastroenterol Nutr. 2012 Sep;55(3):288-91
pubmed: 22314392

Auteurs

Desiree F Baaleman (DF)

Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Pediatric Gastroenterology, Amsterdam, The Netherlands. d.f.baaleman@amsterdamumc.nl.
Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, Netherlands. d.f.baaleman@amsterdamumc.nl.

Carlos A Velasco-Benítez (CA)

Program in Clinical Medicine and Public Health, University of Granada, Granada, Spain.
Department of Pediatrics, Universidad del Valle, Cali, Colombia.

Laura M Méndez-Guzmán (LM)

Department of Pediatrics, Universidad del Valle, Cali, Colombia.

Marc A Benninga (MA)

Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Pediatric Gastroenterology, Amsterdam, The Netherlands.

Miguel Saps (M)

Department of Pediatrics, University of Miami, Miami, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH